Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-03-27_um_07.29.26.png7701700Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-03-26 07:38:002024-07-12 12:22:30Macomics licences macrophage modulator to Ono